Biotech / Medical : Momenta Pharmaceuticals Inc.


 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  
To: tuck who wrote (2868)10/25/2011 10:25:39 AM
From: idosRead Replies (3) of 2948
 
Well, I don't think anyone including Amphastar was expecting the FDA approval in Sep so Sanofi's timing of launching its AG is another surprise. My view on this timing is similar to Peter's ( investorshub.advfn.com  ): that they were preparing for a launch since Sep and probably got a legal opinion from their patent lawyers on the odds for PI that favored a quick launch. On the implication on possible injunction, I agree with ij ( investorshub.advfn.com  ): that MNTA's irreparable harm argument has been damaged by the launch of AG. I don't know what Sanofi will do if MNTA gets its PI, perhaps play with pricing?
Report TOU ViolationShare This Post
 Public Reply | Prvt Reply | Mark as Last Read | FilePrevious 10 | Next 10 | Previous | Next  

Copyright © 1995-2013 Knight Sac Media. All rights reserved.